Cannabis Use Linked to 96% Decreased Risk of Cognitive Decline, Surprising Study Finds

Syracuse, New York – A recent study conducted at the State University of New York Upstate Medical University suggests that cannabis use, whether medical or recreational, could potentially reduce the risk of subjective cognitive decline (SCD). The surprising findings of the study, published in the journal Current Alzheimer Research in February, have sparked interest among researchers.

Contrary to previous research linking cannabis use to cognitive decline, the study found that nonmedical cannabis use was associated with a 96% lower likelihood of experiencing SCD. The coauthor of the study, Roger Wong, Ph.D., expressed astonishment at the unexpected results, highlighting the need for further investigation into the potential benefits of cannabis consumption on cognitive health.

Incorporating data from nearly 4,800 adults aged 45 and older in the United States, researchers examined various factors related to cannabis use, including frequency, purpose, and method of consumption. While the study did not find statistically significant associations between dual use of cannabis, medical use, and decreased risk of SCD, the overall trend suggested a potential protective effect of cannabis on cognitive decline.

Individuals with SCD are known to be at a higher risk of developing dementia and mild cognitive impairment, underscoring the importance of preventive measures. Wong emphasized the significance of early intervention in preventing cognitive decline, potentially mitigating the risk of dementia in later stages of life.

Moreover, the study hinted at a possible link between cannabis use, sleep patterns, and dementia risk. Wong’s previous research has highlighted the impact of sleep difficulties on dementia risk, prompting further exploration into the role of cannabis in improving sleep quality and potentially reducing cognitive decline.

However, the study faces limitations due to the varying legal landscape of cannabis use across different states, as well as the subjective nature of self-reported cognitive health assessments. Future research efforts may focus on longitudinal studies to better understand the long-term effects of cannabis use on cognitive function and overall brain health.

Overall, the study sheds light on the complex relationship between cannabis consumption and cognitive decline, opening avenues for further investigation into the potential benefits and risks associated with cannabis use in the context of cognitive health. The findings challenge existing beliefs and underscore the need for more comprehensive research in this evolving field of study.